These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
82 related articles for article (PubMed ID: 9469265)
1. Alanyl-aminopeptidase activity decrease in cerebrospinal fluid of Alzheimer patients. Iribar MC; Montes J; Gonzalez Maldonado R; Peinado JM Dement Geriatr Cogn Disord; 1998; 9(1):44-9. PubMed ID: 9469265 [TBL] [Abstract][Full Text] [Related]
2. Amino acids and transaminases activity in ventricular CSF and in brain of normal and Alzheimer patients. D'Aniello A; Fisher G; Migliaccio N; Cammisa G; D'Aniello E; Spinelli P Neurosci Lett; 2005 Nov; 388(1):49-53. PubMed ID: 16039064 [TBL] [Abstract][Full Text] [Related]
3. Cerebrospinal fluid levels of non-neurotransmitter amino acids in patients with Alzheimer's disease. Molina JA; Jiménez-Jiménez FJ; Vargas C; Gómez P; de Bustos F; Ortí-Pareja M; Tallón-Barranco A; Benito-León J; Arenas J; Enríquez-de-Salamanca R J Neural Transm (Vienna); 1998; 105(2-3):279-86. PubMed ID: 9660106 [TBL] [Abstract][Full Text] [Related]
4. Amino acid concentration in dementia of the Alzheimer type and multi-infarct dementia. Mochizuki Y; Oishi M; Hara M; Takasu T Ann Clin Lab Sci; 1996; 26(3):275-8. PubMed ID: 8726221 [TBL] [Abstract][Full Text] [Related]
5. Decrease in cytosolic Aspartyl-aminopeptidase but not in Alanyl-aminopeptidase activity in the frontal cortex of the aged rat. Iribar C; Esteban MJ; Martinez JM; Peinado JM Brain Res; 1995 Jul; 687(1-2):211-3. PubMed ID: 7583308 [TBL] [Abstract][Full Text] [Related]
6. Amino acid concentrations in cerebrospinal fluid and plasma in Alzheimer's disease and healthy control subjects. Basun H; Forssell LG; Almkvist O; Cowburn RF; Eklöf R; Winblad B; Wetterberg L J Neural Transm Park Dis Dement Sect; 1990; 2(4):295-304. PubMed ID: 2078309 [TBL] [Abstract][Full Text] [Related]
7. Neurotransmitter amino acids in cerebrospinal fluid of patients with Alzheimer's disease. Jiménez-Jiménez FJ; Molina JA; Gómez P; Vargas C; de Bustos F; Benito-León J; Tallón-Barranco A; Ortí-Pareja M; Gasalla T; Arenas J J Neural Transm (Vienna); 1998; 105(2-3):269-77. PubMed ID: 9660105 [TBL] [Abstract][Full Text] [Related]
8. Free D- and L-amino acids in ventricular cerebrospinal fluid from Alzheimer and normal subjects. Fisher G; Lorenzo N; Abe H; Fujita E; Frey WH; Emory C; Di Fiore MM; D' Aniello A Amino Acids; 1998; 15(3):263-9. PubMed ID: 9871505 [TBL] [Abstract][Full Text] [Related]
9. Free D-amino acids in human cerebrospinal fluid of Alzheimer disease, multiple sclerosis, and healthy control subjects. Fisher GH; Petrucelli L; Gardner C; Emory C; Frey WH; Amaducci L; Sorbi S; Sorrentino G; Borghi M; D'Aniello A Mol Chem Neuropathol; 1994; 23(2-3):115-24. PubMed ID: 7702702 [TBL] [Abstract][Full Text] [Related]
10. A selective reduction of excitatory amino acids in cerebrospinal fluid of patients with Alzheimer type dementia compared with vascular dementia of the Binswanger type. Tohgi H; Abe T; Takahashi S; Kimura M Neurosci Lett; 1992 Jul; 141(1):5-8. PubMed ID: 1508400 [TBL] [Abstract][Full Text] [Related]
11. Amino acid concentrations in cerebrospinal fluid and serum in Alzheimer's disease and vascular dementia. Martinez M; Frank A; Diez-Tejedor E; Hernanz A J Neural Transm Park Dis Dement Sect; 1993; 6(1):1-9. PubMed ID: 8216758 [TBL] [Abstract][Full Text] [Related]
12. Cerebrospinal fluid concentrations of functionally important amino acids and metabolic compounds in patients with mild cognitive impairment and Alzheimer's disease. Kaiser E; Schoenknecht P; Kassner S; Hildebrandt W; Kinscherf R; Schroeder J Neurodegener Dis; 2010; 7(4):251-9. PubMed ID: 20551690 [TBL] [Abstract][Full Text] [Related]
13. Clinicopathologic correlations of soluble amyloid beta-protein precursor in cerebrospinal fluid in patients with Alzheimer disease and controls. Peskind ER; Leverenz J; Farlow MR; Ito RK; Provow SA; Siegel RS; Cleveland M; Morgan CH; Pandian MR; Corbin S; Nochlin D; Schellenberg GD; Raskind MA; Wagner SL Alzheimer Dis Assoc Disord; 1997 Dec; 11(4):201-6. PubMed ID: 9437437 [TBL] [Abstract][Full Text] [Related]
14. Plasma renin-angiotensin system-regulating aminopeptidase activities are modified in early stage Alzheimer's disease and show gender differences but are not related to apolipoprotein E genotype. Puertas Mdel C; Martínez-Martos JM; Cobo M; Lorite P; Sandalio RM; Palomeque T; Torres MI; Carrera-González MP; Mayas MD; Ramírez-Expósito MJ Exp Gerontol; 2013 Jun; 48(6):557-64. PubMed ID: 23500679 [TBL] [Abstract][Full Text] [Related]
15. Analysis of chiral amino acids in cerebrospinal fluid samples linked to different stages of Alzheimer disease. Samakashvili S; Ibáñez C; Simó C; Gil-Bea FJ; Winblad B; Cedazo-Mínguez A; Cifuentes A Electrophoresis; 2011 Oct; 32(19):2757-64. PubMed ID: 21983823 [TBL] [Abstract][Full Text] [Related]